Transaction

Clearwater advises Capital Croissance on the sale of its stake in VLAD to Turenne Santé

Transaction

Capital Croissance sold its stake in VLAD to Turenne Santé

Sell-side

Undisclosed

Role

Adviser to the shareholders of Capital Croissance on the sale of VLAD to Turenne Santé

Sector

Healthcare
Business Services
Industrial & Chemicals

Region

France & Belgium

We have advised Capital Croissance on the sale of its stake in VLAD, France’s leading manufacturer and distributor of batteries for the medical and industrial sectors, to Turenne Santé. Clearwater was the exclusive M&A adviser to Capital Croissance.

Founded in 1985 near Tours, VLAD is specialised in the manufacturing and distribution of high-tech batteries for the medical and industrial markets. The company's success is based on a combination of expertise in logistics and distribution, manufacturing and assembly, design and reconditioning services.

Turenne Santé has acquired a stake in VLAD through a new MBO led by Jean-Louis Jarry (President), Vincent Piton (CEO) and approximately 50 employees who are increasing their shareholding on this occasion. Capital Croissance, the reference shareholder since 2019, is leaving the capital while Bpifrance is increasing its stake in the company.

The entry of Turenne Santé in VLAD’s capital enables the company to pursue its development in France and abroad, through external growth, where targets have already been identified and approached by management.

battery power

We're very proud to have supported the VLAD teams on their fantastic journey over the last five years. Dynamic business development, robotisation of production facilities, construction of a new production site, recruitment and structuring of teams, formalisation of the ESG approach, and so on. We've been through a particularly rich cycle, which opens up some very exciting prospects for VLAD. We are delighted with the assistance provided by Clearwater on this project, who met the challenge with responsiveness, precision, agility and cheerfulness.

ERIC NEUPLANCHE, CHAIRMAN, Capital Croissance

Advisers

Transactions